XML 64 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Taxes [Abstract]  
Schedule Of Income Tax Expense Income tax expense (benefit) consists of the following (in thousands):

Year Ended December 31,

2020

2019

2018

Current

$

(37,047)

$

(2,177)

$

7,758

Deferred

(13,336)

(18,881)

(24,484)

Total

(50,383)

(21,058)

(16,726)

Less: Income tax expense - discontinued operations

-

258

3,421

Income tax benefit - continuing operations

$

(50,383)

$

(21,316)

$

(20,147)

Schedule Of Differences Between The Income Tax Expense (Benefit)Computed At The Statutory Federal income Tax Rate And As Presented On The Consolidated Statements Of Operations

Year Ended December 31,

2020

2019

2018

Tax expense at federal statutory rate

$

(33,698)

$

(36,317)

$

1,060

State income tax expense, net of federal benefit

(802)

(7,839)

702

Nondeductible compensation

421

762

921

Noncontrolling interests

(4,015)

(3,961)

(4,370)

Unrecognized tax benefits

(28)

36

15,148

R&D credits

-

(323)

(34,979)

Increase in valuation allowance

6,279

25,314

-

Disposition of subsidiary

-

(373)

(1,022)

Tax Cuts and Jobs Act impact

-

-

278

Stock compensation

721

369

993

Audit adjustments

-

-

559

Amended return adjustments

(19,786)

-

374

Other

525

1,016

189

Income tax benefit

$

(50,383)

$

(21,316)

$

(20,147)

Schedule Of Significant Components Of Deferred Tax Assets And Liabilities

December 31,

2020

2019

Deferred tax assets:

Net operating loss carryforwards - Federal

$

11,670

$

27,935

Net operating loss carryforwards - State

10,875

8,788

Tax credit carryforwards - Federal

64,081

49,937

Tax credit carryforwards - State

7,369

7,750

Derivative financial instruments

-

342

Deferred revenue

149

795

Interest expense carryforward

6,609

5,539

Investment in partnerships

45,519

46,774

Inventory valuation

290

1,560

Stock-based compensation

1,439

1,347

Accrued expenses

5,351

4,325

Leases

7,958

6,993

Organizational and start-up costs

1,047

-

Other

337

51

Total

162,694

162,136

Valuation allowance

(43,336)

(33,337)

Total deferred tax assets

119,358

128,799

Deferred tax liabilities:

Convertible debt

(9,154)

(12,266)

Fixed assets

(104,364)

(107,909)

Derivative financial instruments

(724)

-

Organizational and start-up costs

-

(4,484)

Right-of-use assets

(5,116)

(4,140)

Total deferred tax liabilities

(119,358)

(128,799)

Deferred income taxes

$

-

$

-

Reconciliation Of The Beginning And Ending Amounts Of Unrecognized Tax Benefits

Unrecognized Tax Benefits

Balance at January 1, 2020

$

51,596

Additions for prior year tax positions

27

Additions for current year tax positions

(54)

Balance at December 31, 2020

$

51,569